Magellan Diagnostics
Magellan Biosciences is provider of point-of-care analyzers and automated systems for hospital-based labs and near-patient testing.
Launch date
Employees
Market cap
-
Enterprise valuation
€60m (Public information from Mar 2016)
Billerica Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$50.0m | Growth Equity VC | ||
$66.0m Valuation: $66.0m | Acquisition | ||
| Total Funding | €45.5m | ||
Recent News about Magellan Diagnostics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.